Healthy men needed to test new cancer drug copycat
NCT ID NCT07299955
First seen Jan 05, 2026 · Last updated May 20, 2026 · Updated 19 times
Summary
This study tests a new drug called Bmab3000 in 150 healthy men aged 18 to 65. It compares Bmab3000 to an approved drug, Herceptin Hylecta, to see how the body absorbs and processes each one. The goal is to check if the new drug works similarly and is safe. Participants receive a single injection under the skin and are monitored for several months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MALE PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Zealand Clinical Research (NZCR)
RECRUITINGChristchurch, Main Building: 264 Antigua Street,, New Zealand
Contact
Conditions
Explore the condition pages connected to this study.